当前位置: X-MOL 学术Stem Cell Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Generation of a serine/threonine-protein kinase LATS1 gene-edited iPSC MUSIi012-A-3.
Stem Cell Research ( IF 0.8 ) Pub Date : 2020-08-06 , DOI: 10.1016/j.scr.2020.101950
Chanchao Lorthongpanich 1 , Chuti Laowtammathron 1 , Nittaya Jiamvoraphong 1 , Pimonwan Srisook 1 , Pimjai Chingsuwanrote 1 , Phatchanat Klaihmon 1 , Supaporn Waeteekul 2 , Yaowalak U-Pratya 3 , Surapol Issaragrisil 4
Affiliation  

In mammals, there are a number of kinases, including serine/threonine-protein kinase LATS1, that act as a core kinase of the Hippo pathway and that negatively regulate the Hippo effector protein YAP and its paralog TAZ. Using CRISPR/Cas9 technology, we established a stable LATS1 knockdown (LATS1-KD) iPSC from the MUSIi012-A cell line. The LATS1-KD iPSC MUSIi012-A-3 that was developed maintained both the normal karyotype and the pluripotent phenotype, and retained the ability to differentiate into all three embryonic germ layers.



中文翻译:

丝氨酸/苏氨酸蛋白激酶LATS1基因编辑的iPSC MUSIi012-A-3的生成。

在哺乳动物中,有许多激酶,包括丝氨酸/苏氨酸蛋白激酶LATS1,它们充当Hippo途径的核心激酶,并负调控Hippo效应蛋白YAP及其旁系TAZ。使用CRISPR / Cas9技术,我们从MUSIi012-A细胞系中建立了稳定的LATS1敲低(LATS1-KD)iPSC。开发的LATS1-KD iPSC MUSIi012-A-3既保持了正常的核型,又保持了多能表型,并保留了分化为所有三个胚芽层的能力。

更新日期:2020-08-06
down
wechat
bug